celiprolol has been researched along with Orphan Diseases in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Orphan Diseases: Rare diseases that have not been well studied.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boutouyrie, P | 1 |
1 review available for celiprolol and Orphan Diseases
| Article | Year |
|---|---|
Topics: Adrenergic beta-Antagonists; Celiprolol; Clinical Trials as Topic; Drug Repositioning; Ehlers-Danlos | 2020 |